Rapid Recognition of Corticosteroid Resistant or Sensitive Sepsis

NARecruitingINTERVENTIONAL
Enrollment

1,800

Participants

Timeline

Start Date

April 10, 2020

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Sepsis
Interventions
DRUG

Administration procedures

"Hydrocortisone hemisuccinate / hydrocortisone placebo will be given as 50 mg intravenous bolus every 6 hours;~9 alpha fludrocortisone / 9 alpha fludrocortisone placebo will be given as a 50 μg tablet via a nasogastric tube once per day in the morning.~Study drugs will be started immediately after randomization (day 0 of the study), until discharge from ICU for a maximal duration of 7 days. Study drugs will be stopped without tapering off."

Trial Locations (1)

92380

RECRUITING

Department of medical and surgical Intensive Care Unit, Raymond Poincaré Hospital - APHP, Garches

All Listed Sponsors
collaborator

Institut National de la Santé Et de la Recherche Médicale, France

OTHER_GOV

collaborator

Versailles Saint-Quentin-en-Yvelines University

OTHER

collaborator

Université Paris-Saclay

OTHER

collaborator

Paris 12 Val de Marne University

OTHER

collaborator

Commissariat A L'energie Atomique

OTHER_GOV

collaborator

Beckman Coulter, Inc.

INDUSTRY

collaborator

Lumedix

UNKNOWN

collaborator

Elice

UNKNOWN

collaborator

Biothelis

UNKNOWN

lead

Assistance Publique - Hôpitaux de Paris

OTHER